Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 3NIH 2OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 2Other solid neoplasm 2Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Ovarian Neoplasms 1773Uterine Cervical Neoplasms 1499Endometrial Neoplasms 833Breast Neoplasms 434Carcinoma, Ovarian Epithelial 405Fallopian Tube Neoplasms 399Uterine Cervical Dysplasia 276Neoplasms 252Colorectal Neoplasms 179Uterine Neoplasms 173Peritoneal Neoplasms 170Vulvar Neoplasms 155Lung Neoplasms 150Pancreatic Neoplasms 141Prostatic Neoplasms 135Recurrence 128Stomach Neoplasms 126Colonic Neoplasms 116Papillomavirus Infections 115Melanoma 101Sarcoma 97Urinary Bladder Neoplasms 95Vaginal Neoplasms 93Carcinoma, Non-Small-Cell Lung 92Head and Neck Neoplasms 91Neoplasm Metastasis 83Esophageal Neoplasms 82Testicular Neoplasms 80Rectal Neoplasms 71Kidney Neoplasms 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Mucinous × Gynecologic × Clear all
NCT03466034 2020-01-29

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Institute of Cancer Research, United Kingdom

Terminated
5 enrolled
Gynecologic

Hypoxia, Adenocarcinoma, Mucinous, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡